Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N. agencies, nonprofit organizations, and commercial partners. The company's development drug candidates include Enobosarm, an oral selective androgen receptor agonist that is in phase III clinical trial for the treatment of AR+ ER+ HER2- metastatic breast cancer; Sabizabulin, which is phase IIb clinical trial for the treatment of AR+ ER+ HER2- metastatic breast cancer; Enobosarm + abemaciclib combination therapy, which is in phase III clinical trial for the treatment of AR+ ER+ HER2- metastatic breast cancer; and Sabizabulin + enobosarm combination therapy, an oral targeted cytoskeleton disruptor plus selective androgen receptor agonist, which is in phase II clinical trial for the treatment of metastatic triple negative breast cancer. Its drug candidates also comprise Sabizabulin, which is in Phase II clinical trial for the treatment of metastatic castration and androgen receptor targeting agent resistant prostate cancer; VERU-100, a GnRH antagonist peptide injection, which is in Phase II clinical trial for the treatment of advanced hormone sensitive prostate cancer; Zuclomiphene Citrate, which is in Phase II clinical trial for treating hot flashes; and Sabizabulin, which is in phase III clinical trial for the treatment of SARS-CoV-2 in subjects at high risk for acute respiratory distress syndrome. In addition, the company is advancing a new drug formulation for the treatment of men with lower urinary tract symptoms from an enlarged prostate. The company was formerly known as The Female Health Company and changed its name to Veru Inc. in July 2017. Veru Inc. was incorporated in 1971 and is headquartered in Miami, Florida.
Veru Dividend Announcement
• Veru announced a quarterly dividend of $0.07 per ordinary share which will be made payable on 2014-05-07. Ex dividend date: 2014-04-28
• Veru's trailing twelve-month (TTM) dividend yield is -%
Veru Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2014-04-28 | $0.07 | quarterly | 2014-05-07 |
2014-01-27 | $0.07 | quarterly | 2014-02-05 |
2013-10-28 | $0.07 | quarterly | 2013-11-06 |
2013-07-29 | $0.07 | quarterly | 2013-08-07 |
2013-04-29 | $0.07 | quarterly | 2013-05-08 |
2013-01-28 | $0.06 | quarterly | 2013-02-06 |
2012-10-31 | $0.06 | quarterly | 2012-11-07 |
2012-10-29 | $0.06 | quarterly | |
2012-07-30 | $0.06 | quarterly | 2012-08-08 |
2012-04-30 | $0.06 | quarterly | 2012-05-09 |
2012-01-30 | $0.05 | quarterly | 2012-02-09 |
2011-10-31 | $0.05 | quarterly | 2011-11-09 |
2011-07-29 | $0.05 | quarterly | 2011-08-09 |
2011-04-29 | $0.05 | quarterly | 2011-05-10 |
2011-01-27 | $0.05 | quarterly | 2011-02-07 |
2010-11-01 | $0.05 | quarterly | 2010-11-10 |
2010-08-02 | $0.05 | quarterly | 2010-08-11 |
2010-04-21 | $0.05 | quarterly | 2010-05-12 |
2010-01-27 | $0.05 | quarterly | 2010-02-16 |
Veru Dividend per year
Veru Dividend growth
Veru Dividend Yield
Veru current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Veru stock? Use our calculator to estimate your expected dividend yield:
Veru Financial Ratios
Veru Dividend FAQ
Other factors to consider when evaluating Veru as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Veru stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Veru's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Veru publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Veru distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Veru are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Veru sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Veru distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Veru declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Veru's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Veru's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.